Search

everythinglearnresearchcommunity

for

Search:↓

FOXN1 gene mutations cause a rare, severe immune disease treatable with cell or tissue transplants.

Myoblast transplantation shows promise for treating various muscle and heart conditions.

Fat tissue transplant may be an effective new treatment for severe, treatment-resistant hair loss from folliculitis decalvans.

Human skin can provide stem cells for tissue repair and regeneration, but there are challenges in obtaining and growing these cells safely.

CD133+ progenitor cells have therapeutic potential for diabetic ulcers and heart attack recovery, with manageable risks.

New treatments for hair loss show promise, including plasma, stem cells, and hair-stimulating complexes, but more research is needed to fully understand them.

Platelet lysate is a promising, cost-effective option for regenerative medicine with potential clinical applications.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

Blue-light activation of TrkA improves hair-follicle stem cells' ability to become neurons and glial cells.

Transplanting skin cells is a safe, effective, and affordable treatment for vitiligo.

The study found that the quality of cord blood units remains consistent before freezing and after thawing, indicating that attached tube segments reliably represent the graft's properties.

PRP treatment showed no hair regrowth improvement after the first application in patients with alopecia.

Adding human blood vessel cells to hair follicle germs may improve hair growth and quality.

Researchers created a quick, cost-effective way to make skin-like tissue from hair follicles and fibroblasts.

Adding stem cells to fat grafts for facial rejuvenation might improve outcomes, but more research is needed to confirm safety and effectiveness.

Scientists turned rat thymus cells into stem cells that can help repair skin and hair.

New regenerative medicine-based therapies for hair loss look promising but need more clinical validation.

Advancements in tissue engineering show promise for hair follicle regeneration to treat hair loss.

Pediatric endocrinologists should provide early fertility counseling and preservation options to young patients at risk of infertility.

Skin stem cells are promising for healing wounds and skin regeneration due to their accessibility and regenerative abilities.

Mice with human fetal thymic tissue and stem cells developed symptoms similar to chronic graft-versus-host disease.

Umbilical cord blood is a valuable source of stem cells for medical treatments, but its use is less common than other transplants, and there are ethical issues to consider.

Stem cells and their exosomes show promise for repairing tissues and healing wounds when delivered effectively, but more research is needed on their tracking and optimal use.

New regenerative therapies show promise for treating hair loss.

Transplant patients face higher skin cancer risks due to immunosuppressive therapy, requiring careful skin health monitoring.

Fetal skin cells from a cell bank heal wounds faster and with less scarring than adult cells.

Hair follicle stem cells could be used to treat the skin condition vitiligo.

Green tea component EGCG helps keep rat skin grafts viable longer.

Fetal-maternal stem cells in a mother's hair can help with tissue repair and regeneration long after childbirth.

Stem cells show promise for hair loss treatment, but no effective product for hair regeneration has been developed yet.